Dawn Carter Bir, Chief Commercial Officer at REATA PHARMACEUTICALS INC (RETA), sold 193,792 shares at $85.90 ($17.0M) on 2023-03-07, disclosed to the SEC on 2023-03-08.
Open-market sale of $17.0M RETA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.30 | 40,134 | $3.6M | 21.1% |
| 2 | $89.30 | 40,134 | $3.6M | 21.1% |
| 3 | $90.26 | 14,820 | $1.3M | 7.9% |
| 4 | $90.26 | 14,820 | $1.3M | 7.9% |
| 5 | $85.08 | 36,049 | $3.1M | 18.1% |
| 6 | $85.08 | 36,049 |
| $3.1M |
| 18.1% |
| 7 | $85.90 | 5,793 | $498K | 2.9% |
| 8 | $85.90 | 5,793 | $498K | 2.9% |
| 9 | $86.67 | 200 | $17K | 0.1% |
| Total | $87.67 avg | 193,792 | $17.0M | 100% |
| Filing → |
| RETA | SELL | 2023-05-17 | $186K | — | Filing → |
| RETA | SELL | 2023-03-15 | $1.6M | — | Filing → |
| RETA | SELL | 2023-03-06 | $382K | — | Filing → |